Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medifarm (later renamed Tikun Australia) was the first Australian medical cannabis company to be licensed by the federal government to cultivate and manufacture medical cannabis. Founded in 2015 and based on Queensland's Sunshine Coast, the company established an exclusive partnership with Israeli medical cannabis pioneer Tikun Olam to access clinically proven cannabis strains. Medifarm focused on providing high-quality, locally grown cannabinoid medicines for patients suffering from conditions such as chronic pain, epilepsy, multiple sclerosis, and PTSD. In July 2022, the company entered voluntary administration due to financial difficulties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medifarm.